Absence of central nervous system effects of practalol [ICI 50,172; 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide], a new adrenergic beta-receptor blocking drug.
D000083:Acetanilides / Q000494:pharmacology*; D000777:Anesthetics / Q000494:pharmacology; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects*; D006591:Hexobarbital / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D000083:Acetanilides; D000777:Anesthetics; D013565:Sympatholytics; D011433:Propranolol; D006591:Hexobarbital; D010433:Pentylenetetrazole